期刊文献+

含乙醇酸、水杨酸、辛酰水杨酸和烟酰胺的外用配方改善轻、中度痤疮症状的临床观察 被引量:5

Clinical efficacy of a topical formula containing glycolic acid,salicylic acid,lipohydroxy acid,and niacinamide in patients with mild to moderate acne
下载PDF
导出
摘要 目的:评价含乙醇酸、水杨酸、辛酰水杨酸和烟酰胺的外用配方改善轻、中度痤疮临床症状的有效性和安全性。方法:招募66例轻、中度女性痤疮患者,按要求使用测试产品28 d后停用14 d,分别在使用前、使用7 d和28 d以及停用7 d和14 d后由皮肤科医生进行痤疮皮损计数、痤疮炎症后红斑和色素沉着计数、毛孔可见度和肤色均匀度评级,拍摄面部标准照片并进行图像分析,并由患者完成自我评价问卷。结果:共有42例患者完成全部试验。与使用前相比,测试产品在使用后7 d和28 d能显著减少非炎性和炎性皮损数量,改善毛孔可见度和肤色均匀度,并且在停用后14 d内仍能维持效果。此外,测试产品对于肤色、红斑程度/面积及血流灌注等图像分析指标也有显著的改善作用。患者对测试产品耐受良好,表现出了较高的满意度和持续使用的意愿。结论:含乙醇酸、水杨酸、辛酰水杨酸和烟酰胺的外用配方对于改善轻、中度痤疮临床症状具有较好的有效性和安全性,减少皮损同时能减轻痤疮炎症后红斑和色素沉着并改善肤质和肤色。 Objective:To evaluate the effectiveness and safety of a topical formula containing glycolic acid,salicylic acid,lipohydroxy acid,and niacinamide in patients with mild to moderate acne.Methods:Sixty-six subjects with mild to moderate acne were recruited and used test product for 28 d and then stopped for 14d.Dermatological evaluations were performed to count acne lesions,quantify post-inflammatory erythema and hyperpigmentation,and grade the extent of pore visibility and skin tone evenness.Standard facial photos were taken,and image analysis was conducted.The subjects also filled self-assessment questionnaires.Results:Forty-two subjects completed the whole study.Comparing to baseline,the test formula reduced non-inflammatory and inflammatory lesions,and improved pore visibility and skin tone evenness at 7 d and 28 d after use.The improvement sustained for 14 d after stopping the use of the product The test formula also produced improvement in skin tone,ery-thema intensity and area,and blood flow,according to the image analysis parameters.The product presented good skin tolerance and the subjects showed satisfaction and willingness for long-term use of it.Conclusion:The topical formula containing glycolic acid,salicylic acid,lipohydroxy acid,and niacinamide showed good effectiveness and safety in patients with mild to moderate acne.It not only reduced lesion count,but also improved post-inflammatory erythema and hyperpigmentation,as well as skin texture and color.
作者 李舒婷 何晓峰 张中兴 Julie CRIBIER Sabina MERALLI-BALLOU Andrew STEEL 鞠强 牛悦青 LI Shu-ting;HE Xiao-feng;ZHANG Zhong-xing;Julie CRIBIER;Sabina MERALLI-BALLOU;Andrew STEEL;JU Qiang;NIU Yue-qing(Research and Innovation Center,L'Oreal China,Shanghai 201206,China)
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2022年第3期175-179,共5页 Journal of Clinical Dermatology
关键词 痤疮 acne
  • 相关文献

参考文献5

二级参考文献31

  • 1钟华,何黎,王玮蓁,许爱娥,易东,王莉,周村建,李红宾,徐延华,王向东,黄萌,单筠筠,陈俊帆,郝飞.维胺酯和异维A酸治疗寻常痤疮随机双盲研究[J].中华皮肤科杂志,2006,39(10):574-576. 被引量:16
  • 2Hakozaki T,Minwalla L,Zhuang J,et al.The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer[J].Br J Dermatol,2002,147(1):20-31.
  • 3Greatens A,Hakozaki T,Koshoffer A,et al.Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible[J].Exp Dermatol,2005,14(7):498-508.
  • 4Bissett DL,Obhmg JE,Berge CA.Niacinamide:A B Vitamin that improves aging facial skin appearance[J].Dermatot Surg,2005,31(7 Pt 2):860-865.
  • 5Tanno O,Ota Y,Kitamura N,et al.Nicotinamide increases biosynthesis of ceramides as well as other stratum comeum lipids to improve the epidermal permeability barrier[J].Br J Dermatol.2000.143(3):524-531.
  • 6Bissett D.Topical niacinamide and barrier enhancement[J].Cutis,2002,70(6 Suppl):8-12.
  • 7Gensler HL,Williams T,Huang AC,et al.Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice[J].Nutr Cancer,1999,34(1):36-41.
  • 8Gensler HL.Prevention of photoimmunosnppression and photoearcinogenesis by topical nicotinamide[J].Nutr Cancer,1997,29(2):157-162.
  • 9Namazi MR.Nicotinamide-containing sunscreens for use in Australasian countries and cancer-provoking conditions[J].Med Hypotheses,2003,60(4):544-545.
  • 10Draelos ZD,Matsubara A,Smiles K.The effect of 2% niacinamide on facial sebum production[J].J Cosmet Laser Ther,2006,8(2):96-101.

共引文献656

同被引文献44

引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部